INS and type 2 diabetes mellitus: The study involved 273 participants aged 18–70 years, with type 2 diabetes for at least 6 months, with HbA1c in the range of 7.0 to 10.0% (53 to 86 mmol/mol), taking at least 2 insulin injections per day for at least 3 months before the study.